- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05745818
Colchicine for Reduction of Periprocedural Myocardial Injury in Percutaneous Coronary Intervention
Study Overview
Status
Intervention / Treatment
Detailed Description
Prospective open-label randomized cohort study including two groups of patients admitted and prepared for elective PCI at cardiology unit, IMD, Sohag University Hospital, these two groups are:
group of patients received oral tablet colchicine 6-24 hours before PCI loading dose 1 mg followed by 500 mcg after one hour.
N.B. usual side effects of colchicine gastrointestinal disorders rarely, myalgia and weakness. Treatment of side effects symptomatic treatment ( antiemetic, etc.)
- control group of patients. Number of patients according to sample size equation.
Sample size equation is used to calculate the minimum size of the required sample:
n = (z)2 p (1- p) / d2
- Number of patients according to sample size equation about 300 patients 150 patient in each group of study.
- Estimated study duration 2 years.
- N.B. Randomization method: first patient prepared to PCI will be included in colchicine group second patient will be included in control group and so on.
Study Type
Enrollment (Anticipated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Elective PCI in ACS patients with cardiac troponin peaked and stabilized and CCS patients .
- PP Myocardial Injury (Any increase in post-PCI troponin if pre-PCI troponin is negative or rise in post-PCI troponin above baseline pre-PCI troponin when it is peaked and stabilized).
- PPMI (rise in post-PCI troponin plus new evidence of ischemia).
Exclusion Criteria:
- Patients with active infections.
- Patients taking anti-inflammatory medications.
- Patients presented with ACS( still rising troponin).
- Severe renal impairment ( creatinine clearance < 45 ml/min ).
- Primary PCI, rescue PCI, pharmacoinvasive therapy.
- Connective tissue diseases.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
control group
|
|
colchicine group
|
oral pills
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MACEs
Time Frame: one month
|
Major Adverse Cardiac Events
|
one month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Ischemia
- Pathologic Processes
- Necrosis
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Myocardial Infarction
- Infarction
- Wounds and Injuries
- Molecular Mechanisms of Pharmacological Action
- Antirheumatic Agents
- Antineoplastic Agents
- Tubulin Modulators
- Antimitotic Agents
- Mitosis Modulators
- Gout Suppressants
- Colchicine
Other Study ID Numbers
- Colchicine study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periprocedural Myocardial Injury
-
Shanghai Zhongshan HospitalUnknownCoronary Artery Disease | Percutaneous Coronary Intervention | Periprocedural Myocardial InjuryChina
-
Hellenic Society of Interventional CardiologyCompletedPeriprocedural Myocardial InfarctionGreece
-
Fundación para la Investigación del Hospital Clínico...Completed
-
University of Roma La SapienzaCompletedRosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs) (ROMA)Periprocedural Myocardial NecrosisItaly
-
Gennaro SardellaCompletedAssess the Periprocedural Myocardial NecrosisItaly
-
University National Heart HospitalCompletedPeriprocedural MyonecrosisBulgaria, Poland
-
San Filippo Neri General HospitalMENDES S.A., Lugano, Switzerland; Università degli studi di Bologna, ItalyUnknownChronic Stable Angina | Periprocedural Myocardial DamageItaly
-
Damascus UniversityCompletedMyocardial Injury | Cardiac Surgery | Myocardial ProtectionSyrian Arab Republic
-
University Hospital Schleswig-HolsteinAbbott; Department of Anaesthesiology and Intensive Care MedicineCompletedMyocardial InjuryGermany
-
Mahidol UniversityCompletedMyocardial InjuryThailand
Clinical Trials on Colchicine Pill
-
Beijing Anzhen HospitalNot yet recruitingST Elevation Myocardial Infarction | Acute Coronary Syndrome | Unstable Angina | Non ST Segment Elevation Myocardial Infarction | ColchicineChina
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI); Population Health Research...Active, not recruitingSTEMI - ST Elevation Myocardial Infarction | Neutrophils.Hypersegmented | Bld-Ser-PlasUnited States
-
Assistance Publique - Hôpitaux de ParisHospices Civils de Lyon; Fonds de Dotation ACTIONNot yet recruiting
-
Population Health Research InstituteActive, not recruitingIntracranial HemorrhagesCanada
-
Bakulev Scientific Center of Cardiovascular SurgeryCompletedAtrial Fibrillation New Onset | Colchicine Adverse ReactionRussian Federation
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR)CompletedAtrial Fibrillation | Thoracic SurgeryCanada
-
Population Health Research InstituteRecruitingInflammation | Peripheral Arterial Disease | Atherosclerosis of ExtremitiesCanada
-
Wuhan Union Hospital, ChinaCompletedCoronary Artery Disease | Percutaneous Coronary InterventionChina
-
Eunice Kennedy Shriver National Institute of Child...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedObesity | Metabolic DiseaseUnited States
-
Montreal Heart InstituteCompletedMyocardial Infarction | Coronary Artery DiseaseCanada